Literature DB >> 11045656

Standards for economic and quality of life studies in transplantation.

J F Whiting1.   

Abstract

There are unique requirements in conducting and reporting economic and quality of life investigations in medicine as compared with more traditional studies involving clinical outcomes. In addition, there are several unique characteristics of the discipline of transplantation that also bear attention in economic and quality of life studies. To provide guidelines for future research and reporting of future research, a consensus conference of transplant professionals was convened to discuss these issues. Five different areas were addressed: "Conducting an Economic Analysis," "Reporting an Economic Analysis," "Quality of Life Studies in Transplantation," "Ethical and Conflict of Interest Issues Between Sponsors and Investigators," and "Future Directions for Research." A series of recommendations for each of these areas with reference to relevant literature is presented.

Mesh:

Year:  2000        PMID: 11045656     DOI: 10.1097/00007890-200010150-00026

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

Review 1.  Measuring patient-reported outcomes in solid organ transplant recipients: an overview of instruments developed to date.

Authors:  Irina Cleemput; Fabienne Dobbels
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

2.  A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results.

Authors:  Karen L Hardinger; Sunny Rhee; Paula Buchanan; Matt Koch; Brent Miller; Decha Enkvetchakul; Rebecca Schuessler; Mark A Schnitzler; Daniel C Brennan
Journal:  Transplantation       Date:  2008-10-15       Impact factor: 4.939

3.  Economic impact and long-term graft outcomes of mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant recipients.

Authors:  Gerardo Machnicki; Jean-Francois Ricci; Daniel C Brennan; Mark A Schnitzler
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  An economic model of 2-hour post-dose ciclosporin monitoring in renal transplantation.

Authors:  Paul A Keown; Bryce Kiberd; Robert Balshaw; Shideh Khorasheh; Carlo Marra; Philip Belitsky; Zoltan Kalo
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

5.  A Cost-Benefit Analysis of Government Compensation of Kidney Donors.

Authors:  P J Held; F McCormick; A Ojo; J P Roberts
Journal:  Am J Transplant       Date:  2015-10-16       Impact factor: 8.086

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.